Global recognition of innovation is complex
Depending on where they are in the world, people with diabetes have disparate access to medicine and solutions. This can be attributed in part to the high costs related to the pandemic nature of diabetes globally and the degree to which health authorities recognize innovation (i.e. Soliqua & Integrated care).
Our ambition is to give all patients equal access to innovation, medicines and solutions worldwide.
We need a strong coalition of PAG, healthcare professionals (HCPs) and policymakers working together to accomplish this goal. The health of people with diabetes depends not only on us, but also on our relationships with patient groups, policymakers, healthcare professionals and society at large, because these groups help shape local policies. Pooling our resources and expertise will ensure that our actions bring tangible benefits to people with diabetes and strengthen the recognition of outstanding development and innovative solutions.